DHR Danaher Corporation

DHR Danaher Corporation

Healthcare · Diagnostics & Research

Desk view

Watchinglow conviction
Perspectives Biotech Capital Cycle

Market read

Scan convergence 1 scan as of 2026-08-14 1 neutral converging

POC $192.73 · VWAP $199.96 · +1.3% vs 12m avg buyer

pullback vol: expandinggaps: stablechurn: quiet as of

Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)

Coverage

3 watchlists

Watchlists @biotech-capital-cycle@biotech-scan@trace-glp1-manufacturing

DHR Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist DHR belongs to, members best 30-day change first — DHR highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@trace-glp1-manufacturing
View watchlist →
BDX+15.1% -0.7%1d +1.4%7d STVN+10.9% +0.9%1d +3.6%7d WAT+10.5% -1.1%1d -1.0%7d TMO+10.0% -0.5%1d -2.3%7d STE+5.5% -1.5%1d -3.9%7d BANB.SW+5.2% -0.5%1d +0.5%7d DHR-0.6% +0.1%1d -3.2%7d LZAGY-0.7% +0.9%1d -2.4%7d WST-3.3% -0.8%1d -1.6%7d
@biotech-capital-cycle
View watchlist →
ABCL+73.1% -1.6%1d +19.9%7d TXG+32.6% +3.4%1d -1.1%7d TWST+32.6% +4.9%1d -0.3%7d CRL+27.8% +2.4%1d +3.4%7d ALMR+23.8% -3.1%1d +14.8%7d AVTR+21.9% -1.2%1d -1.6%7d IQV+17.0% +1.9%1d -0.2%7d GENB+15.7% +0.3%1d +6.6%7d CERT+15.4% 0.0%1d -0.9%7d RGEN+14.8% +1.3%1d +3.6%7d SDGR+13.6% -1.1%1d -7.4%7d A+12.9% -0.1%1d -0.2%7d ABSI+11.3% +0.7%1d +2.5%7d MEDP+11.0% +3.2%1d -0.9%7d WAT+10.5% -1.1%1d -1.0%7d TMO+10.0% -0.5%1d -2.3%7d MTD+8.2% -0.1%1d -0.6%7d RXRX+5.8% -1.6%1d -5.2%7d RVTY+5.5% -0.6%1d +0.1%7d ILMN+3.5% +1.2%1d +0.7%7d XBI+3.4% +1.4%1d +1.0%7d FTRE+1.9% +4.0%1d -4.6%7d SLP+0.7% +0.1%1d +0.1%7d ICLR-0.3% +3.9%1d +2.0%7d DHR-0.6% +0.1%1d -3.2%7d BRKR-1.0% -0.1%1d +2.4%7d TEM-1.6% -0.9%1d -6.2%7d SEER-6.5% -2.4%1d -5.5%7d VKTX-9.3% +1.3%1d -2.2%7d QSI-9.8% 0.0%1d -6.3%7d DNA-12.5% +1.9%1d -9.4%7d AGIO-15.1% +0.2%1d +3.1%7d PACB-16.0% +5.2%1d +4.3%7d LAB-23.6% -4.2%1d -11.5%7d QTRX-24.6% +12.7%1d +21.2%7d CDXS-29.0% +1.9%1d +7.4%7d NAUT-49.4% -1.1%1d +2.3%7d
@biotech-scan
View watchlist →
REGN+19.1% +0.3%1d -0.3%7d IQV+17.0% +1.9%1d -0.2%7d DXCM+15.8% -1.1%1d +1.3%7d AMGN+14.5% +1.0%1d +0.5%7d CRSP+13.6% +1.4%1d +1.6%7d ISRG+13.0% -1.1%1d -0.8%7d A+12.9% -0.1%1d -0.2%7d PTGX+12.6% +2.3%1d +5.9%7d BMRN+11.8% -1.1%1d -3.3%7d TMO+10.0% -0.5%1d -2.3%7d MDT+8.9% -0.7%1d +1.3%7d IMVT+8.6% +4.5%1d +9.8%7d LABU+8.2% +3.9%1d +2.5%7d IONS+7.8% +2.4%1d +3.0%7d NKTR+6.5% -0.5%1d -2.9%7d IBB+6.4% +1.9%1d +0.9%7d NTLA+6.2% +1.5%1d +0.6%7d VRTX+6.2% +1.9%1d -1.6%7d RXRX+5.8% -1.6%1d -5.2%7d SRPT+5.6% +0.4%1d +5.9%7d INCY+5.3% +2.8%1d +1.6%7d IBBQ+5.2% +1.4%1d +0.5%7d KYMR+4.9% +3.4%1d +11.8%7d MRNA+4.3% +1.8%1d +7.7%7d ILMN+3.5% +1.2%1d +0.7%7d GILD+3.5% +0.4%1d +4.4%7d XBI+3.4% +1.4%1d +1.0%7d BIIB+1.5% -0.3%1d +1.0%7d LLY+0.3% +0.3%1d -3.8%7d BNTX+0.1% -1.6%1d -1.3%7d DHR-0.6% +0.1%1d -3.2%7d BEAM-1.6% +1.3%1d -0.6%7d ABBV-1.6% +0.3%1d +1.0%7d COGT-3.1% -0.2%1d -8.7%7d EDIT-4.7% +0.7%1d +0.7%7d LEGN-7.2% +1.4%1d -0.1%7d RARE-10.8% -1.4%1d -2.6%7d NVO-10.8% -2.2%1d -6.0%7d DNA-12.5% +1.9%1d -9.4%7d ALNY-16.0% -1.8%1d +3.5%7d

Decision history

1 scored call · newest first · projection

How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.

May 11 sell n/a Stop loss +12.2% complete

Desk commentary

Authored analysis and challenge notes tied to DHR.

1

Next earnings DHR reports in 63 days Oct 20

Against street estimates

How DHR's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 9 quarters · newest report Jul 21 · projection Aug 17

Result
Jul 21 1.841.94+5.3%Beat
Apr 21 1.942.06+6.5%Beat
Jan 28 2.192.23+2.0%In line
Oct 21 '25 1.721.89+9.8%Beat
Jul 22 '25 1.641.80+9.5%Beat
Apr 22 '25 1.641.88+14.4%Beat
Jan 29 '25 2.162.14-1.1%In line
Oct 22 '24 1.571.71+8.9%Beat

News (last pull)

Headlines about DHR from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 37 days ago · Jul 12

“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.

DHR research tape

39 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.

scan Biotech Scan — August 14, 2026 scan Biotech Scan — August 8, 2026 scan Biotech Scan — July 31, 2026 scan Biotech Scan — July 28, 2026 brief Where Congress's traders actually agree — and where they don't
Types
Aug 14 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 8 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 31 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 28 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 25 Article Where Congress's traders actually agree — and where they don't
NVDAAVGOUBERMASPGIDHR
Jul 25 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 21 Catalyst DHR earnings
DHR
Jul 17 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 11 Scan Biotech Scan
ABBVXBIIBBIBBQLABUMRNABIIBLLY +4 more
Jul 7 Scan Biotech Scan
ABBVXBIIBBIBBQLABUMRNABIIBLLY +4 more
Jun 26 Scan Biotech Scan
ABBVXBIIBBIBBQLABUMRNABIIBLLY +4 more
Jun 25 Article Where the Entries Are
GOOGLAMZNAAPLNVDAAVGOCRWDASMLALAB +4 more
Jun 25 Article Actions Daily Digest
GOOGLAMZNAAPLNVDAAVGOMUSNDKCRWD +4 more
Jun 16 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
May 29 Scan Biotech Scan
AABBVALNYAMGNBEAMBIIBBMRNBNTX +4 more
May 21 Desk Move DHR — mccaul-trades buy
DHR
May 13 Desk Move DHR — mccaul-trades buy
DHR
May 3 Desk Move DHR — mccaul-trades buy
DHR
Apr 28 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCOGT +4 more
Apr 27 Reference Claude-Trader Playbook
ABBVABTADBEASANAVGOCEGCLXCOP +4 more
Apr 27 Reference Claude-Momentum Playbook
ABBVAMZNARMASANAVGOCRMCRSPCRWD +4 more
Apr 26 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCOGT +4 more
Mar 31 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCRSP +4 more
Mar 26 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCRSP +4 more
Mar 24 Scan Biotech Scan
ABBVALNYAMGNBIIBBMRNBNTXCRSPDHR +4 more
Mar 20 Article Market Status Report
ABBVADBEAMKRAMZNARKKASEAVGOCEG +4 more
Mar 20 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCRSP +4 more
Mar 13 Article Market Status Report
AAPLADBEAMDAMKRAMZNARKKASEAVGO +4 more
Mar 13 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCRSP +4 more
Mar 13 Article Daily Actions
AAPLADBEAMZNARMASEASMLBABNTX +4 more
Mar 12 Article Market Status Report
ADBEAMZNARKKAVGOCEGCLXCMGCRM +4 more
Mar 12 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCRSP +4 more
Mar 12 Update Biotech
ALNYBEAMBIIBBNTXCRSPDHRGILDLEGN +4 more
Mar 12 Article Daily Actions
ALERTAMZNARMASEASANASMLBNTXBTC +4 more
Mar 11 Article Market Status Report
ADBEAFRMAMZNARKKASEASANAVGOBNTX +4 more
Mar 11 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBLUEBMRNBNTX +4 more
Mar 11 Article Daily Actions
AMZNARMASEASANASMLBNTXBTCCEG +4 more
Mar 10 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBLUEBMRNBNTX +4 more
Feb 2 Scan Biotech Universe
ABBVALNYAMGNBEAMBIIBBMRNBNTXDHR +4 more